Lynda Schneider
Clinical & Laboratory Immunology · Boston, MANPI 1891891826
Payments from drug & device makers
Across 164 payments — averaging $1489.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$157K
- Pfizer$47K
- Genentech, Inc.$22K
- Sanofi$7K
- LEO Pharma Inc.$5K
- Regeneron Healthcare Solutions, Inc.$5K
- plus $1K from 1 others
Across 13 payments — averaging $714.56 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$9K
- LEO Pharma AS$250
What the payments were for
- Consulting fees$26,85599%
- Travel & lodging$480%
- Food & beverage$2291%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 141 | $157,183 |
| Pfizer | 4 | $46,850 |
| Genentech, Inc. | 3 | $22,228 |
| Sanofi | 5 | $7,140 |
| LEO Pharma Inc. | 2 | $5,360 |
| Regeneron Healthcare Solutions, Inc. | 6 | $4,516 |
| AbbVie | 3 | $1,050 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical & laboratory immunology providers in Massachusettsto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TakhzyroLanadelumab-Flyo | 12 | $648,426 |
Paid to pharmacies, not to this prescriber.
Other clinical & laboratory immunology in Boston
- David SachsBoston$34K
- Richard MoscickiBoston$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.